Table of Content

1 Hepatitis B Vaccines Market Overview
1.1 Hepatitis B Vaccines Product Scope
1.2 Hepatitis B Vaccines Segment by Type
1.2.1 Global Hepatitis B Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Hepatitis B Vaccines Segment by Application
1.3.1 Global Hepatitis B Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Children
1.3.3 Adult
1.4 Hepatitis B Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hepatitis B Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hepatitis B Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hepatitis B Vaccines Price Trends (2016-2027)

2 Hepatitis B Vaccines Estimates and Forecasts by Region
2.1 Global Hepatitis B Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hepatitis B Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hepatitis B Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Hepatitis B Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Hepatitis B Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hepatitis B Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hepatitis B Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hepatitis B Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Hepatitis B Vaccines Estimates and Projections (2016-2027)
2.4.3 China Hepatitis B Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Hepatitis B Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hepatitis B Vaccines Estimates and Projections (2016-2027)
2.4.6 India Hepatitis B Vaccines Estimates and Projections (2016-2027)
3 Global Hepatitis B Vaccines Competition Landscape by Players
3.1 Global Top Hepatitis B Vaccines Players by Sales (2016-2021)
3.2 Global Top Hepatitis B Vaccines Players by Revenue (2016-2021)
3.3 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2020)
3.4 Global Hepatitis B Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Hepatitis B Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hepatitis B Vaccines Market Size by Type
4.1 Global Hepatitis B Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Hepatitis B Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Hepatitis B Vaccines Price by Type (2016-2021)
4.2 Global Hepatitis B Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hepatitis B Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Hepatitis B Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Hepatitis B Vaccines Price Forecast by Type (2022-2027)
5 Global Hepatitis B Vaccines Market Size by Application
5.1 Global Hepatitis B Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Hepatitis B Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Hepatitis B Vaccines Price by Application (2016-2021)
5.2 Global Hepatitis B Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hepatitis B Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Hepatitis B Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Hepatitis B Vaccines Price Forecast by Application (2022-2027)

6 North America Hepatitis B Vaccines Market Facts & Figures
6.1 North America Hepatitis B Vaccines Sales by Company
6.1.1 North America Hepatitis B Vaccines Sales by Company (2016-2021)
6.1.2 North America Hepatitis B Vaccines Revenue by Company (2016-2021)
6.2 North America Hepatitis B Vaccines Sales Breakdown by Type
6.2.1 North America Hepatitis B Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Hepatitis B Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Hepatitis B Vaccines Sales Breakdown by Application
6.3.1 North America Hepatitis B Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Hepatitis B Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Hepatitis B Vaccines Market Facts & Figures
7.1 Europe Hepatitis B Vaccines Sales by Company
7.1.1 Europe Hepatitis B Vaccines Sales by Company (2016-2021)
7.1.2 Europe Hepatitis B Vaccines Revenue by Company (2016-2021)
7.2 Europe Hepatitis B Vaccines Sales Breakdown by Type
7.2.1 Europe Hepatitis B Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hepatitis B Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Hepatitis B Vaccines Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China Hepatitis B Vaccines Market Facts & Figures
8.1 China Hepatitis B Vaccines Sales by Company
8.1.1 China Hepatitis B Vaccines Sales by Company (2016-2021)
8.1.2 China Hepatitis B Vaccines Revenue by Company (2016-2021)
8.2 China Hepatitis B Vaccines Sales Breakdown by Type
8.2.1 China Hepatitis B Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Hepatitis B Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Hepatitis B Vaccines Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Hepatitis B Vaccines Market Facts & Figures
9.1 Japan Hepatitis B Vaccines Sales by Company
9.1.1 Japan Hepatitis B Vaccines Sales by Company (2016-2021)
9.1.2 Japan Hepatitis B Vaccines Revenue by Company (2016-2021)
9.2 Japan Hepatitis B Vaccines Sales Breakdown by Type
9.2.1 Japan Hepatitis B Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hepatitis B Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Hepatitis B Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Hepatitis B Vaccines Market Facts & Figures
10.1 Southeast Asia Hepatitis B Vaccines Sales by Company
10.1.1 Southeast Asia Hepatitis B Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Hepatitis B Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Hepatitis B Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Hepatitis B Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hepatitis B Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hepatitis B Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)

11 India Hepatitis B Vaccines Market Facts & Figures
11.1 India Hepatitis B Vaccines Sales by Company
11.1.1 India Hepatitis B Vaccines Sales by Company (2016-2021)
11.1.2 India Hepatitis B Vaccines Revenue by Company (2016-2021)
11.2 India Hepatitis B Vaccines Sales Breakdown by Type
11.2.1 India Hepatitis B Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Hepatitis B Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Hepatitis B Vaccines Sales Breakdown by Application
11.3.1 India Hepatitis B Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Hepatitis B Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Hepatitis B Vaccines Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Hepatitis B Vaccines Products Offered
12.1.5 GSK Recent Development
12.2 NCPC
12.2.1 NCPC Corporation Information
12.2.2 NCPC Business Overview
12.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 NCPC Hepatitis B Vaccines Products Offered
12.2.5 NCPC Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Hepatitis B Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Bio Kangtai
12.4.1 Bio Kangtai Corporation Information
12.4.2 Bio Kangtai Business Overview
12.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bio Kangtai Hepatitis B Vaccines Products Offered
12.4.5 Bio Kangtai Recent Development
12.5 Dynavax
12.5.1 Dynavax Corporation Information
12.5.2 Dynavax Business Overview
12.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Dynavax Hepatitis B Vaccines Products Offered
12.5.5 Dynavax Recent Development
12.6 Hissen
12.6.1 Hissen Corporation Information
12.6.2 Hissen Business Overview
12.6.3 Hissen Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hissen Hepatitis B Vaccines Products Offered
12.6.5 Hissen Recent Development
12.7 KM Biologics
12.7.1 KM Biologics Corporation Information
12.7.2 KM Biologics Business Overview
12.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 KM Biologics Hepatitis B Vaccines Products Offered
12.7.5 KM Biologics Recent Development
12.8 LG Life Sciences
12.8.1 LG Life Sciences Corporation Information
12.8.2 LG Life Sciences Business Overview
12.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 LG Life Sciences Hepatitis B Vaccines Products Offered
12.8.5 LG Life Sciences Recent Development
12.9 Serum Institute
12.9.1 Serum Institute Corporation Information
12.9.2 Serum Institute Business Overview
12.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Serum Institute Hepatitis B Vaccines Products Offered
12.9.5 Serum Institute Recent Development

13 Hepatitis B Vaccines Manufacturing Cost Analysis
13.1 Hepatitis B Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hepatitis B Vaccines
13.4 Hepatitis B Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hepatitis B Vaccines Distributors List
14.3 Hepatitis B Vaccines Customers

15 Market Dynamics
15.1 Hepatitis B Vaccines Market Trends
15.2 Hepatitis B Vaccines Drivers
15.3 Hepatitis B Vaccines Market Challenges
15.4 Hepatitis B Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Hepatitis B Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hepatitis B Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hepatitis B Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hepatitis B Vaccines Sales (M Doses) by Region (2016-2021)
Table 5. Global Hepatitis B Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hepatitis B Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Hepatitis B Vaccines Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Hepatitis B Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hepatitis B Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hepatitis B Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hepatitis B Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Hepatitis B Vaccines Sales Share by Company (2016-2021)
Table 14. Global Hepatitis B Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hepatitis B Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccines as of 2020)
Table 17. Global Hepatitis B Vaccines Average Price (USD/Doses) of Key Company (2016-2021)
Table 18. Manufacturers Hepatitis B Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Hepatitis B Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hepatitis B Vaccines Sales (M Doses) by Type (2016-2021)
Table 22. Global Hepatitis B Vaccines Sales Share by Type (2016-2021)
Table 23. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2016-2021)
Table 25. Global Hepatitis B Vaccines Sales Share by Type (2022-2027)
Table 26. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hepatitis B Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2022-2027)
Table 29. Global Hepatitis B Vaccines Sales (M Doses) by Application (2016-2021)
Table 30. Global Hepatitis B Vaccines Sales Share by Application (2016-2021)
Table 31. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2016-2021)
Table 33. Global Hepatitis B Vaccines Sales (M Doses) by Application (2022-2027)
Table 34. Global Hepatitis B Vaccines Sales Share by Application (2022-2027)
Table 35. Global Hepatitis B Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hepatitis B Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2022-2027)
Table 38. North America Hepatitis B Vaccines Sales (M Doses) by Company (2016-2021)
Table 39. North America Hepatitis B Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Hepatitis B Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hepatitis B Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)
Table 43. North America Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Hepatitis B Vaccines Sales by Type (2022-2027) & (M Doses)
Table 45. North America Hepatitis B Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)
Table 47. North America Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Hepatitis B Vaccines Sales by Application (2022-2027) & (M Doses)
Table 49. North America Hepatitis B Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Hepatitis B Vaccines Sales (M Doses) by Company (2016-2021)
Table 51. Europe Hepatitis B Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Hepatitis B Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hepatitis B Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Hepatitis B Vaccines Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Hepatitis B Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Hepatitis B Vaccines Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Hepatitis B Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Hepatitis B Vaccines Sales (M Doses) by Company (2016-2021)
Table 63. China Hepatitis B Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Hepatitis B Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hepatitis B Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)
Table 67. China Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Hepatitis B Vaccines Sales by Type (2022-2027) & (M Doses)
Table 69. China Hepatitis B Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)
Table 71. China Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Hepatitis B Vaccines Sales by Application (2022-2027) & (M Doses)
Table 73. China Hepatitis B Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Hepatitis B Vaccines Sales (M Doses) by Company (2016-2021)
Table 75. Japan Hepatitis B Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Hepatitis B Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hepatitis B Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Hepatitis B Vaccines Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Hepatitis B Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Hepatitis B Vaccines Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Hepatitis B Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hepatitis B Vaccines Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Hepatitis B Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hepatitis B Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hepatitis B Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hepatitis B Vaccines Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Hepatitis B Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hepatitis B Vaccines Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Hepatitis B Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Hepatitis B Vaccines Sales (M Doses) by Company (2016-2021)
Table 99. India Hepatitis B Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Hepatitis B Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hepatitis B Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Hepatitis B Vaccines Sales by Type (2016-2021) & (M Doses)
Table 103. India Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Hepatitis B Vaccines Sales by Type (2022-2027) & (M Doses)
Table 105. India Hepatitis B Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Hepatitis B Vaccines Sales by Application (2016-2021) & (M Doses)
Table 107. India Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Hepatitis B Vaccines Sales by Application (2022-2027) & (M Doses)
Table 109. India Hepatitis B Vaccines Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 113. GSK Hepatitis B Vaccines Product
Table 114. GSK Recent Development
Table 115. NCPC Corporation Information
Table 116. NCPC Description and Business Overview
Table 117. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 118. NCPC Hepatitis B Vaccines Product
Table 119. NCPC Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 123. Merck Hepatitis B Vaccines Product
Table 124. Merck Recent Development
Table 125. Bio Kangtai Corporation Information
Table 126. Bio Kangtai Description and Business Overview
Table 127. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 128. Bio Kangtai Hepatitis B Vaccines Product
Table 129. Bio Kangtai Recent Development
Table 130. Dynavax Corporation Information
Table 131. Dynavax Description and Business Overview
Table 132. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 133. Dynavax Hepatitis B Vaccines Product
Table 134. Dynavax Recent Development
Table 135. Hissen Corporation Information
Table 136. Hissen Description and Business Overview
Table 137. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 138. Hissen Hepatitis B Vaccines Product
Table 139. Hissen Recent Development
Table 140. KM Biologics Corporation Information
Table 141. KM Biologics Description and Business Overview
Table 142. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 143. KM Biologics Hepatitis B Vaccines Product
Table 144. KM Biologics Recent Development
Table 145. LG Life Sciences Corporation Information
Table 146. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 147. LG Life Sciences Description and Business Overview
Table 148. LG Life Sciences Hepatitis B Vaccines Product
Table 149. LG Life Sciences Recent Development
Table 150. Serum Institute Corporation Information
Table 151. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 152. Serum Institute Description and Business Overview
Table 153. Serum Institute Hepatitis B Vaccines Product
Table 154. Serum Institute Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Hepatitis B Vaccines Distributors List
Table 158. Hepatitis B Vaccines Customers List
Table 159. Hepatitis B Vaccines Market Trends
Table 160. Hepatitis B Vaccines Market Drivers
Table 161. Hepatitis B Vaccines Market Challenges
Table 162. Hepatitis B Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Vaccines Product Picture
Figure 2. Global Hepatitis B Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hepatitis B Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Children Examples
Figure 7. Adult Examples
Figure 8. Global Hepatitis B Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Hepatitis B Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Hepatitis B Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Hepatitis B Vaccines Price Trends Growth Rate (2016-2027) (USD/Doses)
Figure 12. Global Hepatitis B Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Hepatitis B Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Hepatitis B Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Hepatitis B Vaccines Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Hepatitis B Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Hepatitis B Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Hepatitis B Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Hepatitis B Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Hepatitis B Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Hepatitis B Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Hepatitis B Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Hepatitis B Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Hepatitis B Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Hepatitis B Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Hepatitis B Vaccines Players Market Share by Revenue in Hepatitis B Vaccines: 2016 & 2020
Figure 27. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Hepatitis B Vaccines Revenue Share by Type (2016-2021)
Figure 29. Global Hepatitis B Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Hepatitis B Vaccines Revenue Share by Application (2016-2021)
Figure 31. Global Hepatitis B Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 33. North America Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 34. Europe Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 35. Europe Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 36. China Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 37. China Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 38. Japan Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 39. Japan Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 40. Southeast Asia Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 41. Southeast Asia Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 42. India Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 43. India Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Hepatitis B Vaccines
Figure 46. Manufacturing Process Analysis of Hepatitis B Vaccines
Figure 47. Hepatitis B Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed